Clinical trials and real-world studies consistently show that gastrointestinal symptomsnausea, vomiting, diarrhea and constipationare the most common side effects of GLP-1 receptor agonists.Harvard Health+3Nature+3PMC+3 In obesity trials in particular, constipation often shows up more frequently than it does in type 2 diabetes trials.Taylor & Francis Online+1 As a nutritionist who works every day with people struggling with IBS, chronic constipation, bloating and other functional digestive issues, Im seeing more and more clients who are also using GLP-1 medications
Flexible Access: Choice of convenient in-office visits or virtual telehealth appointments
Retatrutide is an investigational medication not approved by the FDA as of April 2026
This article explores how GLP-1 medications work, their safety profile, NHS prescribing criteria, and alternative evidence-based strategies for managing perimenopausal weight gain
Market trends indicate growing sophistication in amino acid selection, with formulators increasingly choosing ingredients based on scientific evidence rather than traditional preferences